Latest Form 4 insider transactions

NASDAQ
Manish H Shah, a Director of Gibraltar Industries, Inc., received 538 shares of common stock on October 9, 2026.
NYSE
Mark J Scheiwer, EVP, CFO & CAO of Scotts Miracle-Gro Co, reported multiple transactions in common stock on October 2, 2026.
NASDAQ
Dagi Shahar Ben-Noon, Chief Executive Officer and a Director of Inspira Technologies OXY B.H.N. Ltd, purchased 18,181 shares of common stock on October 9, 2026 for $1.67 per share.
NYSE
Danny L Cunningham, a Director of Wec Energy Group, Inc., received 363 shares of common stock on October 7, 2026.
NYSE
Thomas K Lane, a Director of Wec Energy Group, Inc., received 303 shares of common stock on October 7, 2026.
NYSE
Mary Ellen Stanek, a Director of Wec Energy Group, Inc., received 351 shares of common stock on October 7, 2026.
NYSE
Micheal Neil Flanigan, a Director of Avidia Bancorp, Inc., sold 5,000 shares of common stock on September 18, 2026.
NYSE
Saba Capital Management, L.P. reported changes in beneficial ownership of BlackRock ESG Capital Allocation Term Trust common stock on October 7, 2026.
NYSE
Saba Capital Management, L.P. reported changes in beneficial ownership of PIMCO Dynamic Income Strategy Fund common stock on October 7, 2026.
NYSE
Saba Capital Management, L.P. reported changes in beneficial ownership of Gabelli Healthcare & WellnessRx Trust common stock on October 7, 2026.
NYSE
Rubens Aguiar Alvarez, a Director of Bank Bradesco, purchased 1,845,000 shares of common stock on September 1, 2026.
AMEX
Saba Capital Management, L.P. reported changes in beneficial ownership of Ellsworth Growth & Income Fund Ltd common stock on October 7, 2026.
NYSE
Saba Capital Management, L.P. reported changes in beneficial ownership of New Germany Fund Inc common stock on October 7, 2026.
De Lima Filho Pedro Batista, a Director of Brazilian Electric Power Co, sold 837,000 shares of common stock on October 7, 2026 for $11.50 per share.
NASDAQ
William P Scully, a 10% owner of Prothena Corp Public Ltd Co, purchased 215,000 shares of common stock on October 7, 2026.
NASDAQ
Gerard Albert Palana Hernandez, Chief Accounting Officer of VerifyMe, Inc., reported multiple transactions in common stock on September 30, 2026.
NASDAQ
Russel Harold Mcmeekin, Global Corporate President of VerifyMe, Inc., reported multiple transactions in common stock on September 30, 2026.
NASDAQ
Kun Dai, Chief Executive Officer and a Director of Uxin Ltd, purchased 11,836 shares of common stock on October 8, 2026 for $1.13 per share.
NASDAQ
Iron Horse Acquisition II Corp. has released an updated investor presentation detailing its proposed business combination with Electra Vehicles, Inc., a company specializing in AI-powered battery intelligence.
NASDAQ
David R Epstein, a Director of Agomab Therapeutics NV, purchased 5,000 shares of common stock on October 8, 2026 for $8.90 per share.
NASDAQ
Xiaoping Chen, Chief Executive Officer, a Director and 10% owner of Viomi Technology Co., Ltd, reported multiple transactions in common stock on October 8, 2026.
NASDAQ
Chung-Yao Yin, a Director of Gogoro Inc., purchased 14,158,991 shares of common stock on October 7, 2026 for $2.48 per share.
NASDAQ
GigCapital8 Corp. and Quantisimo Corp. have entered into a definitive agreement for a business combination, aiming to list Quantisimo on the Nasdaq under the symbol QSMO.
NASDAQ
Gil Shwed, a Director and 10% owner of Check Point Software Technologies Ltd, reported multiple transactions in common stock on August 5, 2026.
NYSE
Yanjun Wang, CCO and GC of Sea Ltd, sold 2,000 shares of common stock on October 7, 2026.
NASDAQ
C.H. Robinson announced an agreement to acquire RXO, aiming to leverage RXO's capabilities to enhance its own services and expand market reach.
NYSE
C.H. Robinson announced an agreement to acquire RXO, aiming to leverage RXO's capabilities to enhance its own services and expand market reach.
NASDAQ
Troy Wichterman, Chief Financial Officer of Biolife Solutions Inc, reported multiple transactions in common stock on October 6, 2026.
NASDAQ
Joydeep Goswami, a Director of Biolife Solutions Inc, reported a transaction in 53,156 shares of common stock on October 6, 2026.
NASDAQ
Rachel Ellingson, a Director of Biolife Solutions Inc, reported a transaction in 57,995 shares of common stock on October 6, 2026.